Harrison Seth Loring
- SEC CIK
- 0001404955
No open-market purchases or sales filed in the past year.
Current role at each company
- STOK Stoke Therapeutics, Inc.Directoras of Jul 17, 2026
- AKRO Akero Therapeutics, Inc.Directoras of Dec 9, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Harrison Seth Loring as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AKRO Akero Therapeutics, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2022 (view filing) | Oct 25-27 | 2 days | Harrison Seth LoringDirector | SSale | −136.8K | $42.71 | −$5.84M | −44.8%168.5K after | 7 lots |
| Oct 27, 2022 (view filing) | Oct 25-27 | 2 days | Harrison Seth LoringDirector | SSale | −148.7K | $42.71 | −$6.35M | −44.8%183.1K after | 7 lots |
| Nov 1, 2022 (view filing) | Oct 28 | 4 days | Harrison Seth LoringDirector | SSale | −21.1K | $40.31 | −$852.1K | −12.5%147.4K after | 2 lots |
| Nov 1, 2022 (view filing) | Oct 28 | 4 days | Harrison Seth LoringDirector | SSale | −23.0K | $40.31 | −$925.8K | −12.5%160.1K after | 2 lots |
| Dec 2, 2022 (view filing) | Nov 30 | 2 days | Harrison Seth LoringDirector | SSale | −11.1K | $46.94 | −$521.1K | −7.5%136.3K after | 2 lots |
| Dec 2, 2022 (view filing) | Nov 30 | 2 days | Harrison Seth LoringDirector | SSale | −12.0K | $46.94 | −$564.7K | −7.5%148.1K after | 2 lots |